Haidar Maatouk

Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor

Dagmar Kubitza, Michael Becka, Wolfgang Mueck et al. · British Journal of Clinical Pharmacology · 2010 · 431 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +16

Pharmacokinetics and pharmacodynamics of ponesimod, a selective <scp>S1P₁</scp> receptor modulator, in the first‐in‐human study

Patrick Brossard, Hartmut Derendorf, Jian Xu et al. · British Journal of Clinical Pharmacology · 2013 · 111 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Multiple-dose tolerability, pharmacokinetics, and pharmacodynamics of ponesimod, an S1P₁receptor modulator: Favorable impact of dose up-titration

Patrick Brossard, Michael W. Scherz, Atef Halabi et al. · The Journal of Clinical Pharmacology · 2014 · 65 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Impact of Impaired Renal Function on the Pharmacokinetics of the Antiepileptic Drug Lacosamide

Willi Cawello, Uwe Fuhr, Ursula Hering et al. · Clinical Pharmacokinetics · 2013 · 42 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Pharmacokinetics of Teneligliptin in Subjects With Renal Impairment

Atef Halabi, Haidar Maatouk, Karl Ernst Siegler et al. · Clinical Pharmacology in Drug Development · 2013 · 39 citations

Pharmacy, Pharmacokinetics, Pharmacology +15